Johnson & Johnson’s filing comes a month after Medtronic gained U.S. clearance for its Hugo system as competition in the soft ...
16h
Johnson & Johnson Submits OTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration
Johnson & Johnson today announced that the company has submitted the OTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration (FDA) in an application for De Novo classification.
The evolution of robotic surgery has been transformative, reshaping how surgeons perform complex procedures with enhanced precision and control. With the rapid integration of artificial intelligence ...
LINCOLN, Neb.--(BUSINESS WIRE)--Virtual Incision Corporation today announced its De Novo request was submitted and is under substantive review by the U.S. Food and Drug Administration (FDA). The ...
On average, nearly four million annual surgical procedures in the U.S. are completed on pediatric patients. Despite this growing figure, surgical innovation has focused heavily on technologies for ...
The filing comes about a month after competitor Medtronic won FDA approval for the Hugo robotic-assisted surgery system.
Augmented reality (AR) technology has emerged as a game-changer in the field of surgical navigation, revolutionizing the way complex procedures are conducted and significantly improving patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback